# Does Early Re-administration of Aspirin/Clopidogrel Increase the Risk of Bleeding From Artificial Ulcer After EMR or ESD?

> **NCT01621451** · PHASE4 · UNKNOWN · sponsor: **Asan Medical Center** · enrollment: 400 (estimated)

## Conditions studied

- Early Gastric Cancer
- Gastric Dysplasia

## Interventions

- **DRUG:** aspirin and/or clopidogrel
- **DRUG:** aspirin and/or clopidogrel

## Key facts

- **NCT ID:** NCT01621451
- **Lead sponsor:** Asan Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-06
- **Primary completion:** 2014-05
- **Final completion:** 2014-06
- **Target enrollment:** 400 (ESTIMATED)
- **Last updated:** 2012-11-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01621451

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01621451, "Does Early Re-administration of Aspirin/Clopidogrel Increase the Risk of Bleeding From Artificial Ulcer After EMR or ESD?". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT01621451. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*